Streetbeat News

Products Services

AMZN

Amazon's partnership with AI startup Anthropic, backed by Jeff Bezos, has been approved by the UK's competition regulator, the CMA. Despite a $4 billion investment, the CMA found no jurisdictional issues. This partnership is part of Amazon's strategy to enhance its Alexa voice assistant using Anthropic's AI models.

Portfolio Pulse from Benzinga Neuro

September 27, 2024 | 1:52 pm

FXI

SPY

USO

The August PCE inflation data shows a slowdown, which could impact market expectations for interest rates. Oil prices are under scrutiny due to supply uncertainties caused by Hurricane Helene and Middle East tensions. Chinese stocks are rising, driven by government stimulus efforts.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:42 pm

REGN

Regeneron Pharmaceuticals and Sanofi have announced that the FDA has approved Dupixent as the first biologic medicine for treating COPD with an eosinophilic phenotype in the U.S. This approval follows successful Phase 3 trials and previous approvals in the EU and China.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:36 pm

MVPA

OCTA

TTE

TotalEnergies has acquired a 45% stake in Lewis Energy Group's dry gas-producing assets in Texas' Eagle Ford basin, enhancing its U.S. gas value chain presence. This follows a previous acquisition in the same region and strengthens its upstream gas position. TotalEnergies shares are trading higher premarket.

Portfolio Pulse from Lekha Gupta

September 27, 2024 | 1:29 pm

LEXX

LEXXW

Lexaria Bioscience Corp. has received approval to begin a human pilot study on a DehydraTECH-processed oral version of tirzepatide, a drug currently only available via injection. The study aims to evaluate absorption rates and blood sugar control, with results expected by late November.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:24 pm

AVGO

GOOGL

INTC

MSFT

NVDA

SMH

SOXX

The article discusses the ongoing expansion in AI investments by major tech companies like Microsoft, Google, and Meta, and the benefits reaped by Nvidia and Broadcom. Microsoft is investing heavily in AI infrastructure in Brazil and Mexico, while Google is expanding its data centers in South Carolina. Intel is seeking government funding and exploring stake sales, which could impact its subsidy chances. Semiconductor ETFs have seen recent gains.

Portfolio Pulse from Anusuya Lahiri

September 27, 2024 | 1:23 pm

MOMO

PDD

QFIN

XYF

China's expanded stimulus measures, including issuing ¥2 trillion in government bonds and injecting ¥1 trillion into state-owned banks, are expected to benefit certain US-listed Chinese companies. These include Qifu Technology (QFIN), X Financial (XYF), Hello Group (MOMO), and PDD Holdings (PDD), which are anticipated to gain from the economic boost.

Portfolio Pulse from David Pinsen

September 27, 2024 | 1:21 pm

CYTO

Altamira Therapeutics has received an extended ISO 13485 certification for its Bentrio nasal spray, indicating compliance with international quality management standards for medical devices.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:04 pm

ALMS

Alumis has released 28-week data from the open-label extension period of its Phase 2 STRIDE trial for ESK-001. The data indicates that ESK-001 was generally well tolerated, and most patients on the top dose achieved significant improvement in their condition.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:01 pm

KYMR

Kymera Therapeutics (NASDAQ:KYMR) has received varied analyst ratings over the past three months, with a recent positive shift in average price targets. Analysts have raised their price targets, reflecting optimism about the company's future performance. Kymera is a biotechnology firm focused on targeted protein degradation, showing strong revenue growth but facing challenges in asset utilization.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 1:00 pm